Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : MDCO: Medicines Company -- Ignore unavailable to you. Want to Upgrade?

To: Mike who wrote (51)	2/20/2003 1:27:39 AM
From: tuck	Read Replies (2) \| Respond to of 125

Pointer from Erik: Message 18602590 Cheers, Tuck

To: Mike who wrote (51)	3/9/2003 9:52:39 AM
From: Mike	Read Replies (1) \| Respond to of 125

It appears that with the secondary offer with MDCO the chart was not damaged. In fact, we now have developed support at the $18 level. The support is not solid but support none the less. A post was made on Yahoo that sales for Jan were approx $4.3MM. The sales in Dec were stated to be in the $3.6MM range. So looking at the growth it is realistic that we may hit over $5.0MM for March. Remember,the ACC meeting is starting on March 29 in Chicago. The subset analysis will be released at this meeting. Look for Angiomax to be one of the "hot" debated topics of this years ACC. We will have to see if the "Gibson,MD" crowd wins or the truth that Angiomax works? My prediction is we will be at or above a new 52 week high the week of ACC or before. This company is still an unrecognized gem that has failed to win support. They continue to sell Angiomax and convert Dr's. Too bad that no one else is keyed in on this stock. Remember I am in no way a pumper and dumper on MDCO. I do carry a very large position in the stock. I plan on keeping it too till we hit the $30-$35 range sometime in late 2004. Good luck to all, Mike